Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ferrous Fumarate Granules

Approval Number

国药准字H20194044

Company贵州润生制药有限公司

Registration Date

June 21, 2024

Previous Approval Numbers

国药准字H52020918

Drug Information

Generic Name

富马酸亚铁颗粒

Brand Name

仁和

Dosage Form

颗粒剂

Strength

2g：0.2g

Drug Type

化学药品

Registration Date

June 21, 2024

Company Information

Applicant Company

Company Name贵州润生制药有限公司

Company Address

贵州省黔南布依族苗族自治州龙里县医药工业园

Manufacturing Company

Company Name贵州润生制药有限公司

Company Address

贵州省黔南布依族苗族自治州龙里县医药工业园

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

富马酸亚铁颗粒 - NMPA 批准文号 | MedPath